Loading...

PerCP/Cyanine5.5 anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_PerCPCyanine55_CD11b_Antibody_111918
C57BL/6 splenocytes were blocked with TruStain FcX™ (anti-mouse CD16/32) Antibody then stained with Ly-6G/Ly-6C (Gr-1) APC and CD11b (clone M1/70) PerCP/Cyanine5.5 (left) or rat IgG2b, κ PerCP/Cyanine5.5 isotype control (right).
  • M1slash70_PerCPCyanine55_CD11b_Antibody_111918
    C57BL/6 splenocytes were blocked with TruStain FcX™ (anti-mouse CD16/32) Antibody then stained with Ly-6G/Ly-6C (Gr-1) APC and CD11b (clone M1/70) PerCP/Cyanine5.5 (left) or rat IgG2b, κ PerCP/Cyanine5.5 isotype control (right).
Compare all formats See PerCP/Cyanine5.5 spectral data
Cat # Size Price Quantity Save
101227 25 µg ¥16,020
101228 100 µg ¥51,980
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11b antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  2. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  3. Orberg E, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.53. PubMed
  4. Tian WJ, et al. 2021. Clin Exp Pharmacol Physiol. 48:902. PubMed
  5. Ferrao Blanco MN, et al. 2022. Br J Pharmacol. 179:2771. PubMed
  6. Osokine I, et al. 2022. Cell Rep. 38:110329. PubMed
  7. Agarwalla P, et al. 2022. Nat Biotechnol. 40:1250. PubMed
  8. Chae CS, et al. 2022. Cancer Discov. 12:1904. PubMed
  9. Yang K, et al. 2022. Sci Immunol. 7:eabn2888. PubMed
  10. Marquardt RM, et al. 2022. Int J Mol Sci. 23: . PubMed
  11. Halin C, et al. 2022. EMBO J. 41:e111528. PubMed
  12. Auguste YSS, et al. 2022. Nat Neurosci. 25:1273. PubMed
  13. Schepers M, et al. 2023. Brain Behav Immun. 109:1. PubMed
  14. García-García A, et al. 2023. Bioact Mater. 24:174. PubMed
  15. Glaubitz J, et al. 2023. Gut. :. PubMed
  16. Zhang K, et al. 2023. Nat Metab. 5:129. PubMed
  17. Arimoto KI, et al. 2023. Nat Commun. 14:251. PubMed
  18. Zhang B, et al. 2023. Signal Transduct Target Ther. 8:28. PubMed
  19. Lazure F, et al. 2023. Nat Commun. 14:535. PubMed
  20. Murakata Y, et al. 2023. Front Cardiovasc Med. 9:1075358. PubMed
  21. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  22. Drummer C, et al. 2023. Front Immunol. 14:1113883. PubMed
  23. Peng W, et al. 2022. Cell Mol Life Sci. 79:602. PubMed
  24. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  25. Zhu S, et al. 2023. J Nanobiotechnology. 21:81. PubMed
  26. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  27. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  28. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  29. Shen Z, et al. 2023. iScience. 26:106572. PubMed
  30. Haensel D, et al. 2023. Nat Commun. 14:2685. PubMed
  31. Wilden A, et al. 2022. Front Immunol. 13:991295. PubMed
  32. Lang J, et al. 2020. Nat Commun. 11:1338. PubMed
  33. Gordan S, et al. 2020. Cell Reports. 29(10):3033-3046.e4.. PubMed
  34. Milasan A, et al. 2017. J Am Heart Assoc. 10.1161/JAHA.117.006892. PubMed
  35. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  36. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  37. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  38. Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
  39. Grandjean CL, et al. 2021. Sci Adv. 7:. PubMed
  40. Leslie J, et al. 2021. Sci Rep. 11:1415. PubMed
  41. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  42. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  43. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  44. Kim SS, et al. 2022. Cancers (Basel). 14:. PubMed
  45. Hofmann I, et al. 2022. J Pharmacol Exp Ther. Online ahead of print. PubMed
  46. John S, et al. 2020. Sci Rep. 10:11377. PubMed
  47. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  48. Ortiz G, et al. 2020. Front Immunol. 11:1713. PubMed
  49. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  50. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  51. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  52. Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed
  53. Huang X, et al. 2021. Stem Cells Int. 2021:8138374. PubMed
  54. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  55. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  56. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  57. Meng W, et al. 2021. JCI Insight. 6:. PubMed
  58. Zasłona Z, et al. 2014. J Immunol. 193:4245. PubMed
  59. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  60. Kobayashi T, et al. 2019. Cell. 176:982. PubMed
  61. Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
  62. Fu B et al. 2017. Immunity. 47(6):1100-1113 . PubMed
  63. Chen L, et al. 2019. Cell Mol Gastroenterol Hepatol. 7:623. PubMed
  64. Kenichi Shimada et al. 2018. Immunity. 49(5):873-885 . PubMed
  65. Leach SM, et al. 2020. Cell Rep. 33:108337. PubMed
  66. Dong L, et al. 2021. Cancer Cell. . PubMed
  67. Shen Y, et al. 2021. Comput Struct Biotechnol J. 19:5360. PubMed
  68. Súarez-López L, et al. 2021. iScience. 24:103406. PubMed
  69. Amano C, et al. 2015. PLoS One. 10: 0137207. PubMed
  70. Sun P, et al. 2015. J Hepatol. . PubMed
  71. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  72. Biswas S, et al. 2021. Nature. 591:464. PubMed
  73. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  74. Yuan Q, et al. 2021. Cell Reports. 34(5):108724. PubMed
  75. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  76. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  77. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  78. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  79. Khandelwal P, et al. 2013. PLoS One. 8:64193. PubMed
  80. Neubert K, et al. 2014. J Immunol. 192:5830. PubMed
  81. Galle E, et al. 2022. Genome Biol. 23:207. PubMed
  82. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  83. Zhu B, et al. 2021. Immunity. 54(6):1200-1218.e9. PubMed
  84. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  85. Nguyen SL, et al. 2021. Sci Rep. 11:4217. PubMed
  86. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  87. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  88. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  89. Koh EH, et al. 2018. Diabetes. 67(12). PubMed
  90. Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
  91. Jiao H, et al. 2021. Cell. 184(11):2896-2910.e13. PubMed
  92. Lu S, et al. 2020. JCI Insight. 5:00. PubMed
  93. Anastasiou M, et al. 2021. JCI Insight. 6:. PubMed
  94. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  95. Plein A, et al. 2018. Nature. 562:223. PubMed
  96. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  97. Jeong SJ, et al. 2021. Autophagy. 17:3740. PubMed
  98. JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
  99. Bunn P, et al. 2014. J Immunol. 192:3709. PubMed
  100. Nishi C, et al. 2014. Mol Cell Biol. 34:1512. PubMed
  101. Xu G, et al. 2022. Cell Death Dis. 13:888. PubMed
  102. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  103. Gu H, et al. 2018. Aging (Albany NY). 1.525694444. PubMed
  104. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  105. Park D, et al. 2020. Cancer Res. 80:4172. PubMed
  106. Raineri D, et al. 2021. Biomedicines. 10:. PubMed
  107. Bretscher P, et al. 2015. EMBO Mol Med. 7:593. PubMed
  108. Yu Y, et al. 2022. Nat Commun. 13:6857. PubMed
  109. Pereira JA, et al. 2020. Hum Mol Genet. 29:1253. PubMed
  110. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  111. Hu J, et al. 2020. Theranostics. 7.154166667. PubMed
  112. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  113. Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed
  114. Nayak RR, et al. 2021. Cell Host Microbe. 29(3):362-377.e11. PubMed
  115. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  116. Lu CY, et al. 2020. J Neurosci. 40:9602. PubMed
  117. Okamura T, et al. 2021. Front Immunol. 12:669629. PubMed
  118. Qian SJ, et al. 2021. Front Immunol. 12:711337. PubMed
  119. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  120. Fennell LM, et al. 2020. EMBO J. 39:e103303. PubMed
  121. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  122. Li W, et al. 2021. Front Pharmacol. 12:697483. PubMed
  123. Sun L, et al. 2015. J Immunol. 194:4891. PubMed
  124. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  125. Mishra BB, et al. 2017. Nat Microbiol. 2:17072. PubMed
  126. Uribesalgo I, et al. 2019. EMBO Mol Med. 11:e9266. PubMed
  127. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  128. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  129. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  130. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  131. Lu S, et al. 2020. Arterioscler Thromb Vasc Biol. 40:394. PubMed
  132. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  133. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  134. Xu M, et al. 2022. Genes Dis. 9:429. PubMed
  135. Deczkowska A, et al. 2017. Nat Commun. 8:717. PubMed
  136. Chung L et al. 2018. Cell host & microbe. 23(2):203-214 . PubMed
  137. Sasaki T, et al. 2020. Cell Reports. 28(1):202-217.e7.. PubMed
  138. Sharma A, et al. 2020. Cell. 183(2):377-394.e21. PubMed
  139. Liu Z, et al. 2021. Immunity. 54(2):247-258.e7. PubMed
  140. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  141. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
  142. Dagher T, et al. 2021. J Exp Med. 218:. PubMed
  143. Anger-Góra N, et al. 2021. Oncol Lett. 22:582. PubMed
  144. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  145. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  146. Lin W, et al. 2019. EBioMedicine. 49:133. PubMed
  147. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  148. Brown SM et al. 2017. Endocrinology. 158(10):3592-3604 . PubMed
  149. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  150. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  151. Zhao D, et al. 2020. Cancer Discov. 10:1374. PubMed
  152. Cruz-Herranz A, et al. 2021. JCI Insight. 6: . PubMed
  153. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
  154. Stowe CL, et al. 2019. eLife. 0.333333333333333. PubMed
  155. Chatterjee D, et al. 2021. Cell Reports. 35(2):108996. PubMed
  156. Grauel AL, et al. 2020. Nat Commun. 4.84375. PubMed
  157. Wu S, et al. 2022. BMC Immunol. 23:17. PubMed
  158. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  159. Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed
  160. Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
  161. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  162. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  163. Bhattacharya A, et al. 2018. Neuropsychopharmacology. 43:2586. PubMed
  164. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  165. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  166. Chruewkamlow N, et al. 2021. Stem Cell Res Ther. 12:520. PubMed
  167. Vachon L, et al. 2022. Theranostics. 12:1440. PubMed
  168. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  169. Bravo-Caparrós I, et al. 2020. FASEB J. 34:5951. PubMed
  170. Ni C, et al. 2021. Infect Immun. 89:. PubMed
  171. Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed
  172. Tozuka M, et al. 2016. J Dermatol Sci. 82: 38-45. PubMed
  173. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  174. Sharif O, et al. 2013. J Immunol. 190:5640. PubMed
  175. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  176. Muri J, et al. 2020. eLife. 9:e53627.. PubMed
  177. Winchell CG, et al. 2020. Front Immunol. 1.077083333. PubMed
  178. Yu JM, et al. 2019. Nat Commun. 4.388888889. PubMed
  179. Hightower RM, et al. 2019. Mol Ther. 28:189. PubMed
  180. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  181. Bitschar K, et al. 2019. Nat Commun. 10:2730. PubMed
  182. Chen Z, et al. 2019. Mol Med Rep. 19:3210. PubMed
  183. Hsu M, et al. 2022. Nat Immunol. 23:581. PubMed
  184. Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed
  185. Raoof R, et al. 2021. J Neurosci. 41:8249. PubMed
  186. Guo D, et al. 2022. Bone Res. 10:45. PubMed
  187. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  188. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  189. Bennett FC, et al. 2018. Neuron. 98:1170. PubMed
  190. Yang X, et al. 2018. Sci Rep. 8:188. PubMed
  191. Draijer C, et al. 2018. Sci Rep. 8:5105. PubMed
  192. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  193. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  194. Da Mesquita S, et al. 2021. Science Advances. 7(21):. PubMed
  195. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  196. Zhu K, et al. 2022. EMBO Rep. 23:e54499. PubMed
  197. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  198. Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed
  199. Muchenditsi A, et al. 2017. Am J Physiol Gastrointest Liver Physiol. 313:G39. PubMed
  200. Tothova Z et al. 2017. Cell stem cell. 21(4):547-555 . PubMed
  201. Gu H, et al. 2021. Elife. 10:. PubMed
  202. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  203. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  204. Dallari S, et al. 2021. Cell Host Microbe. 29(6):1014-1029.e8. PubMed
  205. Lazarian G, et al. 2021. Cancer Cell. 39(3):380-393.e8. PubMed
  206. Rustenhoven J, et al. 2021. Cell. 184(4):1000-1016.e27. PubMed
  207. Liao Y, et al. 2020. Theranostics. 7.113888889. PubMed
  208. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  209. Xu JL, et al. 2022. Front Pharmacol. 13:911663. PubMed
  210. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  211. Hakim R, et al. 2021. J Neurosci. 41:8441. PubMed
  212. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  213. Hackstein CP, et al. 2022. Nat Commun. 13:7472. PubMed
  214. Starr T, et al. 2018. PLoS One. 13:e0193601. PubMed
  215. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  216. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  217. Meng Michelle Xu et al. 2017. Immunity. 47(2):363-373 . PubMed
  218. Jaitin DA et al. 2016. Cell. 167(7):1883-1896 . PubMed
  219. Zhang J, et al. 2018. Oncoimmunology. 7:e1461301. PubMed
  220. Chen J, et al. 2017. Sci Rep. 10.1038/s41598-017-00654-2. PubMed
  221. Danzer H, et al. 2020. Elife. 9:00. PubMed
  222. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  223. Stefan KL, et al. 2020. Cell. 1312:183. PubMed
  224. Molgora M, et al. 2020. Cell. 182:886. PubMed
  225. Werner A, et al. 2021. iScience. 24:103076. PubMed
  226. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  227. Guey B, et al. 2014. Proc Natl Acad Sci U S A. 111:17254. PubMed
  228. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  229. Lee C, et al. 2020. Front Immunol. 11:77. PubMed
  230. Bohlen CJ et al. 2017. Neuron. 94(4):759-773 . PubMed
  231. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  232. Ishihara J, et al. 2018. Nat Commun. 9:2163. PubMed
  233. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
  234. Maulhardt HA, et al. 2020. Invest New Drugs. 1618:38. PubMed
  235. McDonald MM, et al. 2021. Cell. 184(5):1330-1347.e13. PubMed
  236. Peng V, et al. 2022. Nat Immunol. 23:619. PubMed
  237. Piirainen S, et al. 2021. Glia. 69:2459. PubMed
  238. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  239. Sakamoto K, et al. 2022. STAR Protoc. 3:101052. PubMed
  240. Tummala G, et al. 2021. Invest Ophthalmol Vis Sci. 62:41. PubMed
  241. Lee J, et al. 2015. Nat Commun. 6: 8499. PubMed
  242. Sen D, et al. 2016. PLoS One. 11:e0165064. PubMed
  243. Peltzer N, et al. 2018. Nature. 557:112. PubMed
  244. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
  245. Liddelow S, et al. 2017. Nature. 541:481-487. PubMed
  246. Xu Z, et al. 2020. Cell Rep. 32:108041. PubMed
  247. Ang QY, et al. 2020. Cell. 181(6):1263-1275.e16. PubMed
  248. Zheng C, et al. 2021. J Extracell Vesicles. 10:e12109. PubMed
  249. Tripathi A, et al. 2021. Mol Psychiatry. 26:3043. PubMed
  250. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  251. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  252. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  253. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  254. Han J, et al. 2015. Cancer Res . 75: 5273 - 5282. PubMed
  255. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  256. Strattan E, et al. 2020. Frontiers in Immunology. 2.131944444. PubMed
  257. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  258. Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed
  259. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  260. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  261. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  262. Kapralov AA, et al. 2020. Nat Chem Biol. 278:16. PubMed
  263. Zheng H, et al. 2021. Frontiers in Immunology. 12:645100. PubMed
  264. Chithanathan K, et al. 2022. Biology (Basel). 11:. PubMed
  265. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  266. Erens C, et al. 2022. Biomedicines. 10:. PubMed
RRID
AB_893233 (BioLegend Cat. No. 101227)
AB_893232 (BioLegend Cat. No. 101228)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

How stable is PerCP/Cyanine5.5 tandem as compared to PerCP alone?

PerCP/Cyanine5.5 is quite photostable and also better than PerCP alone in withstanding fixation.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS B550™ anti-mouse/human CD11b M1/70 FC
Spark PLUS V475™ anti-mouse/human CD11b M1/70 FC
StarBright UltraViolet 740 anti-mouse/human CD11b M1/70 FC
StarBright UltraViolet 575 anti-mouse/human CD11b M1/70 FC
Spark YG™ 581 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS YG581™ anti-mouse/human CD11b M1/70 FC
Spark PLUS V450™ anti-mouse/human CD11b M1/70 FC
Go To Top Version: 2    Revision Date: 11/19/2018

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account